MALAT1 and colorectal cancer: The aberrations found in this study (losses of TSC2, COL1A1, NOTCH1, MIR4673 and GNAS, and gains of MALAT1 and TALAM1) may serve as candidate biomarkers for early detection of colorectal cancer onset.